Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 28, 2017No Securities Available for Resale Prior to Effectiveness and Nasdaq-related Approvals
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company has filed a registration statement on...
-
Mar 28, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Mar 21, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has appointed Dennis M. McGrath as its new...
-
Mar 9, 2017Aggregate Private Placement Proceeds Exceed $2.5 Million
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of approximately $1.0 million in additional...
-
Feb 23, 2017Exchange to Provide Incentives for Long-Term Ownership by Existing and New Investors
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) announced today that the Company intends to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common...
-
Feb 17, 2017Fourth Quarter 2016 Financial Results Announced
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced financial results for the fourth quarter and year ended...
-
Feb 3, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical device company, announced that at 4:00 pm today the Securities and Exchange Commission...
-
Feb 2, 2017Company Considering Exchange Offers to Enhance Value of Outstanding Securities
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of a $1.5 million financing. The private...
Dec 19, 2016First product regulatory submission marks major corporate milestoneNEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced that it has filed a 510(k) premarket notification...
-
Dec 2, 2016- Third Quarter 2016 Financial Results Announced -
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced financial results for the third quarter ended September...